1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
One-Time Request for Funding: IND-Enabling and Clinical Studies is sponsored by Washington Research Foundation. A specific solicitation for projects supporting late-stage preclinical development and first-in-human clinical trials of therapeutics. This includes gene and cell therapies, as well as small-molecule or protein-based drugs developed at Washington state institutions.
Geographic focus: Washington state
Focus areas: Therapeutics, Gene Therapy, Cell Therapy, Small-molecule Drugs, Protein-based Drugs, Clinical Trials
Get alerted about grants like this
Get emailed when new opportunities from “Washington Research Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Grants - Washington Research Foundation Advancing breakthrough technologies in Washington state Student program funding opportunity (currently closed) Submit a Technology Commercialization Grant pre-proposal Our grant programs transform innovative research into products and services that will improve health and advance technology for public benefit.
We fund people, projects and programs at nonprofit research institutions in Washington state, while cultivating a vibrant and equitable ecosystem that enables innovators to thrive. Our focus is on life sciences and enabling technologies.
WRF is accepting a one-time request for funding to support late-stage preclinical development and first-in-human clinical trials of therapeutics, including gene and cell therapies, as well as small-molecule or protein-based drugs. Funding is intended for novel products whose intellectual property is owned and managed by a Washington state research institution. For further details, click here.
Technology Commercialization Project-based support leading to the commercial development of products and services Funding for postdoctoral scholars at Washington state research institutions Enabling students to experience STEM research and develop entrepreneurial skills Building the Innovation Ecosystem Foundational support for programs that cultivate innovation and inclusion $186M in grants given since 1993 102 WRF Postdoctoral Fellowships
According to the current listing, eligibility includes: Nonprofit research institutions in Washington state for novel products whose intellectual property is owned and managed by the institution. Confirm the full requirements in the official notice before applying.
One-Time Request for Funding: IND-Enabling and Clinical Studies is funded by Washington Research Foundation. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Washington. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Technology Commercialization Grants (Phased Program) is sponsored by Washington Research Foundation. A phased funding program designed to bridge the gap between discovery research and commercial investment. The program supports the technical development, evaluation, and de-risking of novel technologies at Washington state research institutions to catalyze commercially viable products and services. Geographic focus: Washington state Focus areas: Life Sciences, Enabling Technologies, Medical Devices, Pharmaceuticals, Cell and Gene Therapy, Protein Design
Student Program Funding Opportunity (Washington Research Foundation) is sponsored by Washington Research Foundation. This opportunity supports new or existing student programs related to STEM research and entrepreneurship at nonprofit colleges and universities in Washington state. The foundation seeks to expand access to STEM research opportunities, engage students in entrepreneurship, and promote diversity, equity, and inclusion in STEM fields. Funding can be used for stipends, events, symposia, awards, conference registration and travel, and research supplies.
The Trump administration is renegotiating $33 billion in CHIPS Act grants, demanding equity stakes in Intel, Samsung, and TSMC. With only 24 of 161 milestones completed and applications still open, here is what the new terms mean for semiconductor manufacturers and supply chain companies.
Read articleThe 2026 UMR economic impact report shows NIH funding produced $94 billion in activity and nearly 400,000 jobs — while success rates hit a 30-year low. The strongest economic argument against cutting biomedical research funding, and what researchers should do now.
Read articleNIST launched a sweeping initiative to standardize how AI agents authenticate, interoperate, and stay secure. Companies building autonomous AI systems need to pay attention now.
Read article